Synthroid Side Effects

Generic name: levothyroxine

Note: This page contains side effects data for the generic drug levothyroxine. It is possible that some of the dosage forms included below may not apply to the brand name Synthroid.

Continued below…

For the Consumer

Applies to levothyroxine: oral capsule liquid filled, oral solution, oral tablet

As well as its needed effects, levothyroxine (the active ingredient contained in Synthroid) may cause unwanted side effects that require medical attention.

Major Side Effects

If any of the following side effects occur while taking levothyroxine, check with your doctor immediately:

Less common: Rare

If any of the following symptoms of overdose occur while taking levothyroxine, get emergency help immediately:

Symptoms of overdose:
Continued below…

Minor Side Effects

Some levothyroxine side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

Less common:

Applies to levothyroxine: injection powder for solution

As well as its needed effects, levothyroxine (the active ingredient contained in Synthroid) may cause unwanted side effects that require medical attention.

If any of the following symptoms of overdose occur while taking levothyroxine, get emergency help immediately:

Continued below…

For Healthcare Professionals

Applies to levothyroxine: compounding powder, injectable powder for injection, intravenous powder for injection, oral capsule, oral solution, oral tablet

Cardiovascular

Cardiac function was evaluated in twenty patients requiring TSH suppression for either thyroid goiter or following thyroidectomy and radioactive iodine therapy for thyroid cancer and in twenty age- and sex-matched controls. TSH suppression was associated with an increased incidence of premature ventricular beats, an increased left ventricular mass index, and enhanced left ventricular systolic function. The clinical significance of these changes remains to be determined.[Ref]

Frequency not reported: Palpitations, tachycardia, hypertension, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest[Ref]

Endocrine

Frequency not reported: Changes in symptom presentation for diabetes and adrenal cortical insufficiency[Ref]

Nervous system

Frequency not reported: Headache, hyperactivity, insomnia, seizures[Ref]

Dermatologic

Frequency not reported: Hair loss, flushing, urticaria, pruritus, skin rash, angioedema[Ref]

Musculoskeletal

A study evaluated the effect of long-term thyroid hormone therapy on bone mineral density in 196 women (mean age, 74.4 years) compared to a control group comprised of 795 women (mean age, 72.1 years). The mean daily thyroxine dose was 1.99 mcg/kg (range, 0.3 to 6.6 mcg/kg) with a mean duration of therapy of 20.4 years (range, less than 1 to 68 years). Women taking daily doses of 1.6 mcg/kg or more had significantly lower bone mineral density levels at the ultradistal radius, midshaft radius, hip, and lumbar spine compared to controls. However, estrogen use appeared to negate the adverse effects of thyroid hormone on bone mineral density.

Higher rates of femur fractures have been found in males (p=0.008) prescribed long-term thyroid hormone therapy as compared to controls in a case-control analysis of 23,183 patients, from the United Kingdom General Practice Research Database, prescribed thyroid hormone.[Ref]

Frequency not reported: Tremors, muscle weakness, muscle cramps, increased risk of osteoporosis[Ref]

Continued below…

Gastrointestinal

Frequency not reported: Diarrhea, vomiting, abdominal cramps[Ref]

Genitourinary

Frequency not reported: Menstrual irregularities, impaired fertility[Ref]

Hypersensitivity

Frequency not reported: Serum sickness[Ref]

Metabolic

Frequency not reported: Increased appetite, weight loss[Ref]

Immunologic

Frequency not reported: Autoimmune disorders (e.g., chronic autoimmune thyroiditis)[Ref]

Other

Frequency not reported: Fatigue, heat intolerance, fever, pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children[Ref]

Psychiatric

Frequency not reported: Nervousness, anxiety, irritability, emotional lability[Ref]

References

1. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp." ([2006]):

2. Petersen K, Bengtason C, Lapidus L, et al "Morbidity, mortality, and quality of life for patients treated with levothyroxine." Arch Intern Med 150 (1990): 2077-81

3. Sheppard MC, Holder R, Franklyn JA "Levothyroxine treatment and occurrence of fracture of the hip." Arch Intern Med 162 (2002): 338-43

4. "Product Information. Synthroid (levothyroxine)." Abbott Pharmaceutical, Abbott Park, IL.

5. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

6. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MC "Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH." Clin Endocrinol (Oxf) 37 (1992): 500-3

It is possible that some side effects of Synthroid may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.